|
13. Sankaranarayanan R, Nene BM, Shastri SS et al. HPV screening for cervical cancer in rural India . N Engl J Med 2009; 360: 1385–1394. 14. G Hoste, K Vossaert, and W. A. J.Poppe. The clinical role of HPV testing in primary and secondary cervical cancer screening . Hindawi Publishing Corporation Obstetrics and Gynecology International Volume 2013, article ID 610373. 15. D Saslow, D Solomon, H. W. Lawson et al. American cancer society, American society for colposcopy and cervical pathology, and American society for clinical pathology screening guidelines for the prevention and early detection of cervical cancer, CA: A Cancer Journal for Clinicians, vol 62, N3, pp:147–172, 2012. 16. Prostate Cancer Research Foundation, Rotterdam. 17. World Cancer Report 2014, pp 392–402. 18. Levin TR, Corley DA. Colorecdtal cancer screening – coming of age . N Engl J Med 2013; 369: 1164–1166. 19. Atkin WS, Edwards R, Kralj-Hans I, et al. Once only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomized controlled trial. Lancet 2010; 375: 1624–1633. 20. Sankaranarayanan R, Ramadas K, Somanathan T, et al. Long term effect of visual creening on oral cancer incidence and mortality in a randomized trial in Kerala, India . Oral Oncol 2013; 49: 314–321. 21. Wong BC, et al. Dietary Risk Factors for Gastric Carcinoma – Reply. JAMA 2004; 291: 187–194. 22. Fukase K, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 2008; 372: 392–397. 23. Nam SY et al. Effect of repeated endoscopic screening on the incidence and treatment of gastric cancer in health screenees. Eur J Gastroenterol Hepatol 2009; 21: 855–860. 24. McGlynn KA, London WT. The global epidemiology of hepatocellular carcinoma: present and future. Clin Liver Dis 2011; 15: 223–243. 25. Baffy G, Brunt EM, Caldwell SH. Heaptocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. J Hepatol 2012; 56: 1384–1391. 26. World Cancer Report 2014; pp: 350–361. 27. Aberle DR, Adams AM, Berg CD, et al. National Lung Screening Trial Research Team. Reduced lung cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011; 365: 395–409. 28. McLaughlin JR, Risch HA, Lubinski J, et al. Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: A case-control study . Lancet Oncology 2007; 8(1): 26–34. — 186 —
|